Please login to the form below

Not currently logged in
Email:
Password:

Pfizer’s Elizabeth Barrett joins Novartis as its oncology head

She succeeds Bruno Strigini who retires

Elizabeth BarrettNovartis has appointed Elizabeth Barrett to head up its oncology franchise based at the group’s headquarters in Switzerland.

Barrett, who succeeds Bruno Strigini, has held numerous leadership positions in the pharmaceutical industry as well as in the commercial sector.

She most recently served Pfizer, leading its oncology business but has held several roles with the pharma giant including president, Europe, president North America, speciality care and US president of oncology.

She said: “I feel honoured to join Novartis. It is key to me to contribute to transformative advancements in oncology, and to serve in a highly impactful leadership role to this end.”

Prior to her time with Pfizer, Barrett held roles with Cephalon and Johnson & Johnson.

Vas Narasimhan, chief executive officer at Novartis, said: “Liz is a highly accomplished and recognised oncology and people leader with an impressive record of building successful business organisations in the US.

“She has been instrumental in creating new commercial models, driving innovation in close partnership with research and development and leveraging business development opportunities.

“Her long-time commercial pharma industry experience, marketing skills and perspectives make Liz a great fit to further develop our oncology business.”

12th January 2018

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics